NewAmsterdam Pharma Company N.V. ( NAMS) - Key Metrics
NAMS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.52 | -$0.57 | -$0.57 |
| 2026Q1 | $0.03 | -$0.40 | -$0.25 | -$0.25 |
| 2025Q4 | $0 | -$0.65 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.61 | -$0.28 | -$0.28 |
| 2025Q2 | $0.17 | -$0.15 | -$0.33 | -$0.34 |
NAMS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -16.29 |
| 2026Q1 | 0% | -20.01 |
| 2025Q4 | 0% | -13.49 |
| 2025Q3 | 0% | -11.66 |
| 2025Q2 | 0% | -30.18 |
NAMS
Price: $28.08
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 billion